First, we grouped the 9736 TCGA cancer cohorts into high or low RNA expressions of EGFR, mTOR, NOS2, TGFB1, mTOR, and FGFR1 and compared the survival of cohorts from the two groups. This evidence concerns the gene MTOR and cancer.